Alterations in plasma and brain amino acids after administration of the glycine/NMDA receptor partial agonist, d-cycloserine, to mice and rats

By Baran H.   Gramer M.   Loscher W.  

European Journal of Pharmacology, Vol. 273, Iss. 1, 1995-01 ,pp. : 197-201

Elsevier

Access to resources Recommend Favorite

A partial agonist model used in the allosteric modulation of the NMDA receptor - II. Assessment of the antinociceptive activity of combinations of competitive and non-competitive NMDA antagonists with agents acting at allosteric-glycine and polyamine receptor sites

By Robichon R.   Randall P.K.   Leslie S.W.  

European Journal of Pharmacology, Vol. 328, Iss. 2, 1997-09 ,pp. : 255-263

Elsevier

Access to resources Recommend Favorite

Temperature and agonist dependency of tachykinin NK 1 receptor antagonist potencies in rat isolated superior cervical ganglion

By Hawcock A.B.   Beresford I.J.M.   Marshall F.H.   Hagan R.M.  

European Journal of Pharmacology, Vol. 294, Iss. 1, 1995-01 ,pp. : 163-171

Elsevier

Access to resources Recommend Favorite

Activation of c-fos mRNA in the brain by the -opioid receptor agonist enadoline and the NMDA receptor antagonist dizocilpine

By Panegyres P.K.   Hughes J.  

European Journal of Pharmacology, Vol. 328, Iss. 1, 1997-09 ,pp. : 31-36

Elsevier

Access to resources Recommend Favorite

Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor

By Wood M.D.   Boyfield I.   Nash D.J.   Jewitt F.R.   Avenell K.Y.   Riley G.J.  

European Journal of Pharmacology, Vol. 407, Iss. 1, 2000-10 ,pp. : 47-51

Elsevier

Access to resources Recommend Favorite